Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Neuroscience Research|August 9, 2001
Induction of the proinflammatory cytokine interleukin-18 by axonal injuryT Menge, S Jander, G StollDer Nervenarzt|November 1, 2011
[Alemtuzumab: a further option for treatment of multiple sclerosis]T Menge, B C Kieseier, C Warnke, et al.Angiology|May 1, 1981
Comparative long-term results of patients with carotid artery stenosisP Walter, V Bänfer, T Menge, et al.Der Nervenarzt|February 4, 2009
[Targeting B cells in multiple sclerosis. Current concepts and strategies]T Menge, H-C Büdingen, M C Dalakas, et al.Der Nervenarzt|September 28, 2004
[Statins for treatment of CNS diseases. Status report from research and clinical practice]T Menge, H-C von Büdingen, S S Zamvil, et al.Der Nervenarzt|May 23, 2013
[Teriflunomide for treatment of multiple sclerosis]C Warnke, G Meyer Zu Hörste, T Menge, et al.Transfusion|January 11, 2013
Spray-dried plasma and fresh frozen plasma modulate permeability and inflammation in vitro in vascular endothelial cellsK Wataha, T Menge, X Deng, et al.Clinical and Experimental Immunology|October 10, 2013
Requirement for safety monitoring for approved multiple sclerosis therapies: an overviewP S Rommer, U K Zettl, B Kieseier, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2013
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartumM Ringelstein, J Harmel, F Distelmaier, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in childrenP H Lalive, M G Häusler, H Maurey, et al.Pageof 2